Search research articles
Contact Us
Filters
Showing results (411-420 of 562) with videos related to
Page
of 57
Sort By:
Nature Communications
|
November 26, 2014
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR
Anne-Theres Henze, Boyan K Garvalov, Sascha Seidel, et al.
Neuro-Oncology
|
June 29, 2021
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N Louis, Arie Perry, Pieter Wesseling, et al.
Cell Death Discovery
|
April 5, 2022
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma
Kai Voeltzke, Katerina Scharov, Cornelius Maximilian Funk, et al.
Oncogene
|
December 14, 2011
Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro
L M Dittmann, A Danner, J Gronych, et al.
Gastroenterology
|
January 24, 2012
Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome
Mario Heindl, Norman Händel, Joanne Ngeow, et al.
Journal of Neuropathology and Experimental Neurology
|
June 6, 2007
Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome
Johan M Kros, Thierry Gorlia, Mathilde C Kouwenhoven, et al.
Cancer Research
|
July 18, 2008
Temozolomide preferentially depletes cancer stem cells in glioblastoma
Dagmar Beier, Stefanie Röhrl, Deepu R Pillai, et al.
The Lancet. Oncology
|
August 1, 2014
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Michael Weller, Martin van den Bent, Kirsten Hopkins, et al.
Molecular Cancer Therapeutics
|
September 1, 2011
Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation
Anja Uhmann, Hannah Niemann, Bérénice Lammering, et al.
Cancer Cell
|
October 19, 2013
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma
Qi-Wen Fan, Christine K Cheng, W Clay Gustafson, et al.
Page
of 57
Search research articles
Search
Showing results (411-420 of 562) with videos related to
Sort By:
Page
of 57
Nature Communications
|
November 26, 2014
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR
Anne-Theres Henze, Boyan K Garvalov, Sascha Seidel, et al.
Neuro-Oncology
|
June 29, 2021
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N Louis, Arie Perry, Pieter Wesseling, et al.
Cell Death Discovery
|
April 5, 2022
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma
Kai Voeltzke, Katerina Scharov, Cornelius Maximilian Funk, et al.
Oncogene
|
December 14, 2011
Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro
L M Dittmann, A Danner, J Gronych, et al.
Gastroenterology
|
January 24, 2012
Autoimmunity, intestinal lymphoid hyperplasia, and defects in mucosal B-cell homeostasis in patients with PTEN hamartoma tumor syndrome
Mario Heindl, Norman Händel, Joanne Ngeow, et al.
Journal of Neuropathology and Experimental Neurology
|
June 6, 2007
Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome
Johan M Kros, Thierry Gorlia, Mathilde C Kouwenhoven, et al.
Cancer Research
|
July 18, 2008
Temozolomide preferentially depletes cancer stem cells in glioblastoma
Dagmar Beier, Stefanie Röhrl, Deepu R Pillai, et al.
The Lancet. Oncology
|
August 1, 2014
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Michael Weller, Martin van den Bent, Kirsten Hopkins, et al.
Molecular Cancer Therapeutics
|
September 1, 2011
Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation
Anja Uhmann, Hannah Niemann, Bérénice Lammering, et al.
Cancer Cell
|
October 19, 2013
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma
Qi-Wen Fan, Christine K Cheng, W Clay Gustafson, et al.
Page
of 57